Publications

Original Article

Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo

Cancer Vaccines

2017

Authors:

Cecil DL, Slota M, O'Meara MM, Curtis BC, Gad E, Dang Y, Herendeen D, Rastetter L, Disis ML.

Journal:

Clinical Cancer Research

Volume:

23(13)

Page:

3396-3404

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/28039264/

Review Article

Precancer Atlas to Drive Precision Prevention Trials

2017

Authors:

Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M, Kay NE, Braggio E, Vilar E, Mazzilli SA, Rebbeck TR, Garber JE, Velculescu VE, Disis ML, Wallace DC, Lippman SM.

Journal:

Cancer Research

Volume:

77(7)

Page:

1510-1541

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/28373404/

Review Article

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

Measuring Human Immunity

2017

Authors:

Gnjatic S, Bronte V, Brunet LR, Butler MO, Disis ML, Galon J, Hakansson LG, Hanks BA, Karanikas V, Khleif SN, Kirkwood JM, Miller LD, Schendel DJ, Tanneau I, Wigginton JM, Butterfield LH.

Journal:

Journal of Immunotherapy of cancer

Volume:

Page:

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/28515944/

Original Article

Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer

Clinical Trials

2017

Authors:

John B Liao, Ron E Swensen , Kelsie J Ovenell , Katie M Hitchcock-Bernhardt, Jessica L Reichow, Minjun C Apodaca, Leonard D'Amico, Jennifer S Childs, Doreen M Higgins, Barbara J Buening, Barbara A Goff, Mary L Disis

Journal:

Gynecologic Oncology

Volume:

144(3)

Page:

480-485

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/28089377/

Original Article

Gene expression markers of Tumor Infiltrating Leukocytes

Tumor Microenvironment

2017

Authors:

Danaher P, Warren S, Dennis L, D'Amico L, White A, Disis ML, Geller MA, Odunsi K, Beechem J, Fling SP.

Journal:

Journal of Immunotherapy Cancer

Volume:

Page:

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/28239471/

Original Article

The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 Dependent

T Cell Function & Therapy

2016

Authors:

Vy Phan-Lai, Yushe Dang, Ekram Gad, Jennifer Childs, and Mary L. Disis

Journal:

Clinical Cancer Research

Volume:

22(9)

Page:

2207-16

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/26660518/

Review Article

Clinical significance of tumor-infiltrating lymphocytes in breast cancer

T Cell Function & Therapy

2016

Authors:

Sasha E Stanton and Mary L Disis

Journal:

Journal for Immunotherapy of Cancer

Volume:

Page:

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/27777769/

Review Article

Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review

2016

Authors:

Stanton SE, Adams S, Disis ML.

Journal:

JAMA Oncology

Volume:

2(10)

Page:

1354-1360

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/27355489/

Original Article

Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity

Tumor Microenvironment

2016

Authors:

Dietsch GN, Lu H, Yang Y, Morishima C, Chow LQ, Disis ML, Hershberg RM.

Journal:

PLoS One

Volume:

11(2)

Page:

e0148764

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/26928328/

Original Article

Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer

Cancer Vaccines

2016

Authors:

Ebben JD, Lubet RA, Gad E, Disis ML, You M.

Journal:

Molecular Carcinogensis

Volume:

55(11)

Page:

1517-1525

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/26346412/